Moderna Newsroom

Wolfe Research Downgrades Moderna(MRNA.US) to Sell Rating, Cuts Target Price to $40

Futu News05:31

Deutsche Bank Adjusts Price Target on Moderna to $60 From $75, Keeps Hold Rating

MT NewswiresNov 12 20:44

Barclays lowered moderna's target price to $111.

Gelonghui FinanceNov 12 16:44

A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $60 to $112

Futu NewsNov 9 21:10

Moderna Analyst Ratings

BenzingaNov 9 05:16

Moderna Price Target Cut to $111.00/Share From $125.00 by Barclays

Dow JonesNov 9 02:58

Moderna Is Maintained at Overweight by Barclays

Dow JonesNov 9 02:58

BofA Securities Adjusts Price Target on Moderna to $90 From $110, Maintains Neutral Rating

MT NewswiresNov 8 23:36

A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $55 to $111

Futu NewsNov 8 21:15

Moderna Analyst Ratings

BenzingaNov 8 18:01

Brookline Capital Cuts Moderna's Price Target to $212 From $238

MT NewswiresNov 8 02:49

Moderna Is Maintained at Underweight by JP Morgan

Dow JonesNov 4 22:59

Moderna Analyst Ratings

BenzingaNov 4 22:50

Evercore Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $60

Futu NewsOct 28 20:31

UBS Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $108

Futu NewsOct 25 07:31

Moderna Is Maintained at Buy by UBS

Dow JonesOct 25 01:27

Moderna Analyst Ratings

BenzingaOct 25 01:19

Piper Sandler Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $115

Futu NewsOct 24 19:31

TD Cowen Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $60

Futu NewsOct 21 19:34

Moderna Analyst Ratings

BenzingaOct 18 00:38